ED
EXAS

Exane Derivatives’s Exact Sciences EXAS Stock Holding History

Exane Derivatives’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1.38K Sell
35
-2,865
-99% -$153K ﹤0.01% 472
2022
Q1 		$203K Hold
2,900
– – 0.06% 330
2021
Q4 		$226K Sell
2,900
-408
-12% -$36K 0.05% 317
2021
Q3 		$316K Buy
3,308
+3,024
+1,065% +$319K 0.08% 276
2021
Q2 		$32.5K Buy
+284
New +$33.9K 0.01% 677

Other funds holding EXAS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Exane Derivatives's EXAS Position: Q2 2022 in Review

Exane Derivatives reduced its Exact Sciences (EXAS) stake by 99% in Q2 2022, selling an estimated $153K and leaving 35 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #472.

Exane Derivatives first reported a position in EXAS in Q2 2021 and has held it in 5 quarters since. The position peaked at $316K in Q3 2021. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • Exane Derivatives held 35 shares of Exact Sciences worth $1.38K as of Q2 2022.
  • Exane Derivatives sold 2,865 Exact Sciences shares in Q2 2022, an estimated $153K.
  • Exact Sciences made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #472 holding.
  • Exane Derivatives first reported a position in Exact Sciences in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's Exact Sciences position peaked at $316K in Q3 2021.
  • 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.